3.Centers for Disease Control and Prevention. Cases of Ebola virus disease in Africa, 1976–2015. https://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/index.html. Accessed 14 March 2016.
4.Maganga GD Kapetshi J Berthet N Ebola virus disease in the Democratic Republic of Congo. N Engl J Med 2014; 371:2083–91.25317743 [PubMed]
5.WHO Ebola Response Team, Aylward B Barboza P Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371:1481–95.25244186 [OpenAIRE] [PubMed]
6.Muyembe-Tamfum JJ Mulangu S Masumu J Kayembe JM Kemp A Paweska JT Ebola virus outbreaks in Africa: past and present. Onderstepoort J Vet Res 2012; 79:451.23327370 [PubMed]
7.Breman JG Heymann DL Lloyd G Discovery and description of Ebola Zaire virus in 1976 and relevance to the West African epidemic during 2013–2016. J Infect Dis 2016; 214 Suppl 3:S93–101.27357339 [OpenAIRE] [PubMed]
8.Rosello A Mossoko M Flasche S Ebola virus disease in the Democratic Republic of the Congo, 1976–2014. Elife 2015; 4.
9.Natesan M Jensen SM Keasey SL Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses. Clin Vaccine Immunol 2016; 23:717–24.27335383 [OpenAIRE] [PubMed]
10.Corti D Misasi J Mulangu S Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 2016; 351:1339–42.26917593 [PubMed]
11.Bond N Schieffelin JS Moses LM Bennett AJ Bausch DG A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection. Am J Trop Med Hyg 2013; 88:241–4.23390223 [OpenAIRE] [PubMed]
12.Johnson KM Webb PA Heymann DL Evaluation of the plasmapheresis program in Zaire. Ebola virus hemorrhagic fever. In: Pattyn SR (ed). Ebola virus hemorrhagic fever. Amsterdam: Elsevier, 1978.
13.World Health Organization. Case definition recommendations for Ebola or Marburg Virus Diseases. Technical Guidelines for Integrated Disease Surveillance and Response (IDS) in the Africa Region. Geneva: World Health Organization, 2014.
14.Yang ZY Duckers HJ Sullivan NJ Sanchez A Nabel EG Nabel GJ Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000; 6:886–9.10932225 [OpenAIRE] [PubMed]
15.Burbelo PD Goldman R Mattson TL A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol 2005; 5:22.16109166 [OpenAIRE] [PubMed]